| Mepha Pharma AG - Rivastigmin-Mepha Patch 13.3mg/24h, transdermale Pflaster |
| 66880 | | 03 | | Rivastigmin-Mepha Patch 13.3mg/24h | | transdermale Pflaster | | N06DA03 | | Rivastigmine | | 15.01.2018 | | |
|
| Composition |
| rivastigminum 20.7 mg, excipiens ad praeparationem pro 13.8 cm² cum liberatione 13.8 mg/24h. |
| Packungsbestandteile |
| Transdermal patch | | | | | | | | Active Agent | Dose |
|---|
| Rivastigmine | 20.7 mg |
| | BAG: Active Agent | Dose |
|---|
| Rivastigmine | 20.7 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
